Corcept Therapeutics Q4 2013 Earnings Report

Total Revenue
$4.12M
Previous year: $1.38M
+199.2%
EPS
-$0.11
Previous year: -$0.09
+22.2%

Corcept Therapeutics

Corcept Therapeutics